{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:53:07Z","timestamp":1791273187969,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"Commission europ\u00e9enne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lungcan.2026.109544","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:51:20Z","timestamp":1784533880000},"page":"109544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7267-1079","authenticated-orcid":false,"given":"Roberta","family":"Noberini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8107-4940","authenticated-orcid":false,"given":"Ioanna","family":"Bischinioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2241-2823","authenticated-orcid":false,"given":"Simone","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-1544","authenticated-orcid":false,"given":"Giulia","family":"Sedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eltjona","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bardoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-7369","authenticated-orcid":false,"given":"Giulia","family":"Robusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"D\u2019Ercole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9726-3653","authenticated-orcid":false,"given":"Rosanna","family":"Mancari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-3334","authenticated-orcid":false,"given":"Luca","family":"Bertolaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1663-0528","authenticated-orcid":false,"given":"Mariano","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-9131","authenticated-orcid":false,"given":"Nicola","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-7211","authenticated-orcid":false,"given":"Domenico","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3556-1265","authenticated-orcid":false,"given":"Tiziana","family":"Bonaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109544_b0005","doi-asserted-by":"crossref","unstructured":"B. Bertin, M. Zugman, G. Schvartsman, The current treatment landscape of malignant pleural mesothelioma and future directions, cancers (Basel) 15(24) (2023).","DOI":"10.3390\/cancers15245808"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109544_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the surveillance, epidemiology, and end results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J. Surg. Res."},{"issue":"10272","key":"10.1016\/j.lungcan.2026.109544_b0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.lungcan.2026.109544_b0020","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-16-0229","article-title":"Genomic landscape of malignant mesotheliomas","volume":"15","author":"Kato","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109544_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/pp-2016-0007","article-title":"Comparative genetics of diffuse malignant mesothelioma tumors of the peritoneumand pleura, with focus on BAP1 expression","volume":"1","author":"Brevet","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109544_b0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109544_b0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lungcan.2026.109544_b0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13148-017-0369-8","article-title":"PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples","volume":"9","author":"Noberini","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.lungcan.2026.109544_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky224","article-title":"Extensive and systematic rewiring of histone post-translational modifications in cancer model systems","author":"Noberini","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lungcan.2026.109544_b0050","article-title":"Enrichment of histones from patient samples for mass spectrometry-based analysis of post-translational modifications","author":"Noberini","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.lungcan.2026.109544_b0055","doi-asserted-by":"crossref","unstructured":"R. Noberini, C. Restellini, E.O. Savoia, F. Raimondi, L. Ghiani, M.G. Jodice, G. Bertalot, G. Bonizzi, M. Capra, F.A. Maffini, M. Tagliabue, M. Ansarin, M. Lupia, M. Giordano, D. Osti, G. Pelicci, S. Chiocca, T. Bonaldi, Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer, Cancers (Basel) 11(5) (2019).","DOI":"10.3390\/cancers11050723"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109544_b0060","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1074\/mcp.M115.054510","article-title":"Pathology tissue-quantitative mass spectrometry analysis to profile histone post-translational modification patterns in patient samples","volume":"15","author":"Noberini","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.lungcan.2026.109544_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-0716-2863-8_7","article-title":"A Super-SILAC approach for profiling histone posttranslational modifications","volume":"2603","author":"Noberini","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109544_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13148-021-01120-7","article-title":"Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples","volume":"13","author":"Noberini","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109544_b0075","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1021\/acs.jproteome.8b00133","article-title":"EpiProfile 2.0: a computational platform for processing epi-proteomics mass spectrometry data","volume":"17","author":"Yuan","year":"2018","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109544_b0080","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109544_b0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizcaino","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109544_b0090","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1038\/s41467-025-63745-z","article-title":"A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes","volume":"16","author":"Noberini","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109544_b0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.65.2.27","article-title":"Mass Spectrometry-based profiling of histone post-translational modifications in uveal melanoma tissues, human melanocytes, and uveal melanoma cell lines - a pilot study","volume":"65","author":"Herwig-Carl","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109544_b0100","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3892\/ijo.2016.3335","article-title":"KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma","volume":"48","author":"Cregan","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109544_b0105","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1093\/nar\/gky224","article-title":"Extensive and systematic rewiring of histone post-translational modifications in cancer model systems","volume":"46","author":"Noberini","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109544_b0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmech.2011.11.001","article-title":"George Zheng, 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site","volume":"47","author":"Ghizzoni","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109544_b0115","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1021\/acs.jmedchem.3c00039","article-title":"Acetyl-click screening platform identifies small-molecule inhibitors of histone acetyltransferase 1 (HAT1)","volume":"66","author":"Gaddameedi","year":"2023","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109544_b0180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109544_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003518","article-title":"Histone acetyl transferase 1 is essential for mammalian development, genome stability, and the processing of newly synthesized histones H3 and H4","volume":"9","author":"Nagarajan","year":"2013","journal-title":"PLoS Genet."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109544_b0125","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/ijc.30897","article-title":"Asbestos-associated genome-wide DNA methylation changes in lung cancer","volume":"141","author":"Kettunen","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2026.109544_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383125","article-title":"Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma","volume":"15","author":"Matull","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109544_b0135","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109544_b0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tcb.2024.06.001","article-title":"Roles of H3K4 methylation in biology and disease","volume":"35","author":"Wang","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.lungcan.2026.109544_b0145","unstructured":"C.J. Terranova, M. Maitituoheti, A.T. Raman, M. Tang, N.E. Anvar, A.K. Ghosh, S.B. Amin, J. Schulz, E. Orouji, F. Giancotti, P. Troncoso, C.J. Logothetis, T. Thompson, K. Rai, H3K4me1-marked Enhancer Activation in Resistant Prostate Cancers Implicates SOX4 and MENIN Inhibition as Therapeutic Strategies, bioRxiv (2021) 2021.09.02.458625."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109544_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13092","article-title":"Hdac3, Setdb1, and Kap1 mark H3K9me3\/H3K14ac bivalent regions in young and aged liver","volume":"19","author":"Price","year":"2020","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109544_b0155","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41467-017-02259-9","article-title":"H3K14ac is linked to methylation of H3K9 by the triple Tudor domain of SETDB1","volume":"8","author":"Jurkowska","year":"2017","journal-title":"Nat. Commun."},{"issue":"7866","key":"10.1016\/j.lungcan.2026.109544_b0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-021-03520-4","article-title":"Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity","volume":"595","author":"Griffin","year":"2021","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.lungcan.2026.109544_b0165","doi-asserted-by":"crossref","first-page":"13757","DOI":"10.18632\/oncotarget.3765","article-title":"Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors","volume":"6","author":"Sacco","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109544_b0170","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/JTO.0b013e3181c5e366","article-title":"Histone deacetylase inhibitors in malignant pleural mesothelioma: preclinical rationale and clinical trials","volume":"5","author":"Paik","year":"2010","journal-title":"J. Thorac. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:24:30Z","timestamp":1791271470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S0169500226006057"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109544","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109544"}}